Roland Schmieder (Germany) answers the following questions: - Please share with us your thoughts on the Symplicity HTN-3 press release...
Markus Schlaich (Australia) answers the following questions: - Can you tell us more about the RHC "fil rouge" patients presented in Berlin, and the objectives of using these patients?...
RHC 2014 - Discover the presentations from the third session.
Download the slides if you would like to learn more about “personalised medicine” and the different possible antihypertensive drug combinations for the three “fil rouge” patients with elevated blood pressure: an elderly atherosclerotic patient, a metabolic patient and a young adrenergic patient.
What are the key steps to evaluate a patient with uncontrolled hypertension?
RHC 2014 - Discover the presentations from the second session.
Download the slides if you would like to understand how to systematically evaluate a patient with uncontrolled hypertension. The session comprehensively discusses the different modalities to measure blood pressure, assess the personalised patient risks, and it also includes key data for drug adherence.
Read about the results of the CORAL study selected in The New England Journal of Medicine and commented by Sebastian Ewen.
Discover the first session held during RHC 2014: What are the key mechanisms involved in hypertension?
You made this second edition a lively and highly interactive educational experience!
Last day but not least! The 3rd day of the Resistant Hypertension Course looks forward to the future